Research Article: Awareness of HBV Functional Cure and Attitude Toward Related Clinical Trials Among Patients with Chronic Hepatitis B in China
Introduction:
Hepatitis B virus (HBV) infection is a global public health concern, and patients with HBV infection are at high risk of progressive liver diseases and hepatocellular carcinoma (HCC). China has the largest chronic hepatitis B (CHB) burden with an estimated .% hepatitis B surface antigen (HBsAg) seroprevalence rate and . per , all-age death rate for HBV-related diseases in . Increasing levels of HBV DNA, HBsAg, and ALT were associated with an increasing risk of HCC. Studies have reported that HBsAg seroclearance…
Read more